The Vita Coco Company heads into its Q2 earnings today with options traders making one of the most aggressively bullish bets on the stock seen in the past year — even as short sellers pile in and insiders have been cashing out at pace.
The clearest standout is in the options market. The put/call ratio has collapsed to 0.20, more than two standard deviations below its 20-day average of 0.34 — a reading that puts call demand near its highest relative level of the past twelve months. That is a sharp break from the prior three weeks, when the ratio held steadily between 0.35 and 0.44. Options traders are leaning hard into upside into the print. That bullishness lands against a stock that has lost 11% over the past month to $74.45, making the positioning feel more like a contrarian bet on a recovery than a momentum chase.
Short interest tells a more cautious story, and it is worth naming the divergence directly. Bears have added meaningfully — short interest has climbed 10% over the past week and 15% over the past month, now running at 9% of the free float. That is a meaningful short position for a consumer brand. Critically, though, the borrow market is not strained. Availability is ample at 838% — roughly eight shares available to borrow for every one already lent out — and the cost to borrow is just 0.55%, despite doubling over the past month. Short sellers are building positions, but doing so from a position of easy access rather than desperation. Availability has tightened sharply from above 1,300% earlier in July, suggesting demand for borrows is accelerating even if the absolute level remains loose.
The bull and bear cases are well-defined. Bulls point to mid-teens category growth, strong brand positioning in coconut water, and an EPS surprise factor ranking in the 86th percentile — this is a company with a history of beating estimates. After Q1 results in late April, the stock jumped 28% on the day and 33% over the following five days. After the most recent print in early June, it barely moved, falling less than 1%. Analysts who have updated targets recently are constructive: Piper Sandler lifted its target to $74 from $70 earlier this month, and the consensus target sits at $77 — fractionally above current levels, suggesting the Street sees limited upside from here even in the bull case. The mean price target has been chased higher by a stock that rallied strongly from its lows; the valuation cushion has compressed. Bears focus on lingering tariff exposure, rising G&A costs, and demand elasticity risk if pricing pushes too hard. Insiders appear to share some of that caution — founder Ira Liran sold nearly $21 million of stock in two sessions in mid-June, and COO Jonathan Burth has sold $6 million across three separate transactions since May. Net insider selling over the past 90 days totals roughly $55 million.
The Q2 print is therefore less a test of whether Vita Coco is growing and more a question of whether the company can sustain category momentum at the margins the Street currently prices in — with options traders wagering on yes, and a growing short position wagering on no.
See the live data behind this article on ORTEX.
Open COCO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
